3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Public Health -

Study sees no eye cancer risk from cell phones

Cancer • • Public HealthJan 14, 09

Regular mobile phone use does not appear to increase a person’s risk of getting a type of cancer called melanoma of the eye, German researchers said on Tuesday.

The study involving about 1,600 people detected no link between the time a person spent using a cell phone over about a decade and their chances of developing melanoma of the eye, they wrote in the Journal of the National Cancer Institute.

The findings contradicted an earlier, smaller study by the same researchers that had raised concern about such a link.

Melanoma is an aggressive form of cancer that can spread quickly. It arises in cells that produce the pigment called melanin that gives skin its color. The eyes also have cells that produce melanin. Melanoma of the eye is rare.

The condition also is called uveal melanoma.

The issue of whether long-term use of cell phones can cause cancer, in particular brain tumors, has been a hot topic, but most studies examining the matter have found no such association.

“We did not corroborate our previous results that showed an increased risk of uveal melanoma among regular mobile phone users,” Dr. Andreas Stang of the Martin-Luther-University of Halle-Wittenberg in Germany wrote in the journal.

“Uncertainty exists about the role, if any, of radio waves transmitted by radio sets or mobile phones in human carcinogenesis (cancer development),” they added.

WASHINGTON (Reuters)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  Sex and violence may not really sell products
  New drug for neuroblastoma shows promise in phase I study
  GPs and the Fit for Work scheme
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  Study shows global warming is unlikely to reduce winter deaths
  Academies make recommendations for improving public health
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  As death rates drop, nonfatal diseases and injuries take a bigger toll on health globally

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site